- Home
- NGEN vs ARQQ Comparison
NGEN vs ARQQ Comparison
Compare NGEN & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGEN | ARQQ |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.6M | 315.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NGEN | ARQQ |
|---|---|---|
| Price | $4.21 | $16.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 114.9K | ★ 237.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $381.13 |
| Revenue Next Year | N/A | $212.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.73 | $11.00 |
| 52 Week High | $5.93 | $62.00 |
Technical Indicators
Market Signals| Indicator | NGEN | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 39.96 | 39.23 |
| Support Level | $3.73 | $15.05 |
| Resistance Level | $4.50 | $32.35 |
| Average True Range (ATR) | 0.25 | 1.07 |
| MACD | 0.05 | 0.30 |
| Stochastic Oscillator | 50.00 | 46.38 |
Price Performance
Historical ComparisonAbout NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.